🇺🇸 FDA
Pipeline program

MaaT033 capsule

2024-517018-14-00

Phase 2 small_molecule active

Quick answer

MaaT033 capsule for NSCLC (Advanced Non-small Cell Lung Cancer) is a Phase 2 program (small_molecule) at REGENERON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
REGENERON PHARMACEUTICALS, INC.
Indication
NSCLC (Advanced Non-small Cell Lung Cancer)
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials